Novartis stocks drug cabinet with “Big-3” arthritis blockbusters

Novartis stocks drug cabinet with “Big-3” arthritis blockbusters

Comments Off on Novartis stocks drug cabinet with “Big-3” arthritis blockbusters

ZURICH (Reuters) – Switzerland’s Novartis is stocking up cheaper versions of the world’s top-selling arthritis medicines, hoping a broad portfolio gives it an edge on rivals with narrower offerings. Reuters:... Read More

Shire gets injunction against Roche over hemophilia drug

Shire gets injunction against Roche over hemophilia drug

Comments Off on Shire gets injunction against Roche over hemophilia drug

ZURICH (Reuters) – Pharmaceutical group Shire said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche over its hemophilia drug emicizumab, alleging incomplete and... Read More

Big pharma turns to AI to speed drug discovery, GSK signs deal

Big pharma turns to AI to speed drug discovery, GSK signs deal

Comments Off on Big pharma turns to AI to speed drug discovery, GSK signs deal

LONDON (Reuters) – The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $ 43 million... Read More

Pfizer, Roche and Aspen face South African probe into cancer drug prices

Pfizer, Roche and Aspen face South African probe into cancer drug prices

Comments Off on Pfizer, Roche and Aspen face South African probe into cancer drug prices

PRETORIA (Reuters) – South Africa’s competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency’s chief said on Tuesday. Reuters: Health News... Read More

Roche CEO still optimistic on new breast cancer drug

Roche CEO still optimistic on new breast cancer drug

Comments Off on Roche CEO still optimistic on new breast cancer drug

VIENNA (Reuters) – Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker’s... Read More

FDA warns of foot, leg amputations with J&J diabetes drug

FDA warns of foot, leg amputations with J&J diabetes drug

Comments Off on FDA warns of foot, leg amputations with J&J diabetes drug

(Reuters) – Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration... Read More

AstraZeneca asthma drug fails, after similar setback at Roche

AstraZeneca asthma drug fails, after similar setback at Roche

Comments Off on AstraZeneca asthma drug fails, after similar setback at Roche

(Reuters) – An experimental biotech drug for severe asthma from AstraZeneca failed to meet its goal of significantly reducing attacks in a late-stage study, dealing a blow to an approach... Read More